✦ LIBER ✦

Randomized, double-blind, placebo-controlled study to evaluate the safety, pharmacokinetics and pharmacodynamics of avagacestat (BMS 708163) in healthy Japanese and non-Japanese subjects

✍ Scribed by Randy Dockens; Ellen Chung; Oleksandr Sverdlov; Holly Soares; Bing He; Michael Furlong; Gary Tong

Book ID: 118468463
Publisher: Elsevier Science
Year: 2012
Tongue: English
Weight: 53 KB
Volume: 8
Category: Article
ISSN: 1552-5260
DOI: 10.1016/j.jalz.2012.05.517

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Randomized, double-blinded, placebo-cont

Randomized, double-blinded, placebo-controlled study to evaluate the safety, pharmacokinetics, and pharmacodynamics of avagacestat (BMS 708163) in healthy Japanese and non-Japanese subjects

✍ Randy Dockens; Ellen Chung; Oleksandr Sverdlov; Holly Soares; Bing He; Michael F 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 59 KB

A Placebo-Controlled, Multiple Ascending

A Placebo-Controlled, Multiple Ascending Dose Study to Evaluate the Safety, Pharmacokinetics and Pharmacodynamics of Avagacestat (BMS-708163) in Healthy Young and Elderly Subjects

✍ Randy Dockens, Jun-Sheng Wang, Lorna Castaneda, Oleksandr Sverdlov, Shu-Pang Hua 📂 Article 📅 2012 🏛 Springer International Publishing AG 🌐 English ⚖ 542 KB

Randomized, placebo-controlled, double b

Randomized, placebo-controlled, double blind, single- and multiple-dose study to evaluate the pharmacokinetics, safety and tolerability of avagacestat (BMS-708163) in healthy young male and elderly male and female Chinese subjects

✍ Jennifer Karkas; Randy Dockens; Oleksandr Sverdlov; Heather Sevinsky; Bing He; G 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 53 KB

A randomized, double-blind, placebo-cont

A randomized, double-blind, placebo-controlled, single-dose study to evaluate the safety, tolerability, pharmacokinetics and pharmacodynamics of denosumab administered subcutaneously to postmenopausal Japanese women

✍ Yuji Kumagai; Tomoko Hasunuma; Desmond Padhi 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 697 KB

737 A PHASE-I, RANDOMIZED, DOUBLE-BLIND,

737 A PHASE-I, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY TO EVALUATE THE SAFETY, TOLERABILITY, PHARMACOKINETICS AND PHARMACODYNAMICS OF SINGLE ESCALATING ORAL DOSES OF GS-9620 IN HEALTHY SUBJECTS

✍ U. Lopatin; G. Wolfgang; R. Kimberlin; D. Turnas; M. Cornprost; G. Chittick; C. 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 46 KB

162 A RANDOMIZED DOUBLE-BLIND, PLACEBO-C

162 A RANDOMIZED DOUBLE-BLIND, PLACEBO-CONTROLLED, SINGLE AND MULTIPLE ASCENDING DOSE STUDY TO EVALUATE THE SAFETY AND PHARMACOKINETICS OF OCR-002 IN HEALTHY VOLUNTEERS

✍ P. Jochelson; J.L. van de Wetering; J. Bornstein; M. Resler; K. Anderson 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 39 KB